Your browser doesn't support javascript.
loading
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas.
Tesfa, Daniel; Sander, Birgitta; Lindkvist, Henric; Nilsson, Christer; Kimby, Eva; Hägglund, Hans; Wahlin, Björn E; Klimkowska, Monika; Palmblad, Jan.
Afiliación
  • Tesfa D; The Hematology Center and Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge R51, 141 86, Stockholm, Sweden.
  • Sander B; Swedish Orphan Biovitrum AB, 112 76, Stockholm, Sweden.
  • Lindkvist H; Department of Clinical Pathology and Cytology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, 141 86, Stockholm, Sweden.
  • Nilsson C; The Hematology Center and Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge R51, 141 86, Stockholm, Sweden.
  • Kimby E; The Hematology Center and Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge R51, 141 86, Stockholm, Sweden.
  • Hägglund H; The Hematology Center and Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge R51, 141 86, Stockholm, Sweden.
  • Wahlin BE; The Hematology Center and Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge R51, 141 86, Stockholm, Sweden.
  • Klimkowska M; Division of Hematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Palmblad J; The Hematology Center and Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge R51, 141 86, Stockholm, Sweden.
Med Oncol ; 38(6): 70, 2021 May 18.
Article en En | MEDLINE | ID: mdl-34003398
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Factor Estimulante de Colonias de Granulocitos / Factor Activador de Células B / Rituximab / Antineoplásicos Inmunológicos / Neutropenia Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Factor Estimulante de Colonias de Granulocitos / Factor Activador de Células B / Rituximab / Antineoplásicos Inmunológicos / Neutropenia Tipo de estudio: Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Suecia